Cash and cash equivalents (USD, thousands)

Accounts receivable, net (USD, thousands)

Inventories, net (USD, thousands)

Prepaid and other current assets (USD, thousands)

Total current assets (USD, thousands)

Equipment, net (USD, thousands)

Right-of-use asset - operating lease (USD, thousands)

Goodwill (USD, thousands)

Intangible asset, net (USD, thousands)

Non-current inventory and other assets (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued expenses and other current liabilities (USD, thousands)

Operating lease liability, current portion (USD, thousands)

Contingent consideration, current (USD, thousands)

Total current liabilities (USD, thousands)

Contingent consideration, non-current (USD, thousands)

Loan payable, long-term (USD, thousands)

Operating lease liability, long-term (USD, thousands)

Finance lease liability, long-term (USD, thousands)

Total liabilities (USD, thousands)

Common stock, $ 0.0001 par value per share (150,000,000 shares authorized, ...) (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated deficit (USD, thousands)

Total stockholders’ equity (USD, thousands)

Total liabilities and stockholders’ equity (USD, thousands)

a5c6ce8457fa791eb2268b6b4e7378dd1e9334ac128a0f2b05b97e90c91bc526

United States

Outside of the United States

- Royalty Revenue

Total Revenue

277fe17b59dfbef92492a9b4be5e2bdc765dd5e7fa5944622327d5696bc2afe0

Product Sales, Net (USD, thousands)

Royalty and Milestone Revenue (USD, thousands)

Total Revenues (USD, thousands)

Cost of Revenue (excl. Amortization & Depreciation) (USD, thousands)

Research and Development Expenses (USD, thousands)

Selling, General and Administrative Expenses (USD, thousands)

Loss in Fair Value of Contingent Consideration (USD, thousands)

Gain in Fair Value of Contingent Consideration (USD, thousands)

Intangible Asset Amortization (USD, thousands)

Total Operating Expenses (USD, thousands)

Loss from Operations (USD, thousands)

Interest Expense, Net (USD, thousands)

Loss Before Income Taxes (USD, thousands)

Income Tax Expense (USD, thousands)

Net Loss (USD, thousands)

Net Loss per Common Share, Basic and Diluted (USD)

Weighted Average Common Shares Outstanding, Basic and Diluted (shares)

12f12473ae32876d1e62121ab50e6fe576e4d2899e946b7455a1f0e54d7891db

Stock-based Compensation Expense (USD, thousands)

Amortization of Intangible Asset (USD, thousands)

Amortization of Debt Discount (USD, thousands)

Depreciation (USD, thousands)

Loss (Gain) in Fair Value of Contingent Consideration (USD, thousands)

Non-cash Lease Expense (USD, thousands)

Change in Operating Lease Liability (USD, thousands)

Net Cash Used in Operating Activities (USD, thousands)

Purchases of Equipment (USD, thousands)

Net Cash Used in Investing Activities (USD, thousands)

Payments on Principal Portion of Finance Lease Obligation (USD, thousands)

Proceeds from Issuance of Common Stock upon Financing (USD, thousands)

Cash Paid for Common Stock Issuance Costs (USD, thousands)

Proceeds from Issuance of Common Stock upon Exercise of Options and ESPP (USD, thousands)

Payment of Contingent Consideration (USD, thousands)

Payments of Tax Withholdings on Stock Awards (USD, thousands)

Net Cash Provided by Financing Activities (USD, thousands)

Net (Decrease) Increase in Cash (USD, thousands)

Interest Paid (USD, thousands)

Operating Lease Right-of-use Asset Obtained for Liability (USD, thousands)

Accounts Receivable, Net (USD, thousands)

Inventories, Net (USD, thousands)

Prepaid Expenses and Other Current Assets (USD, thousands)

Non-current Inventory and Other Assets (USD, thousands)

Accounts Payable (USD, thousands)

Accrued Expenses and Other Current Liabilities (USD, thousands)

Cash at Beginning of Period (USD, thousands)

Cash at End of Period (USD, thousands)

5bbcac7f8b1ae888fd21c1f3f028165b7cbb1c2254b1de2e82378210631fb650

Auvelity

Sunosi

- Sunosi Royalty

- Sunosi License Revenue

32098ac42b8e604f62718457f32475211b6b864a8ac9b70fb427f3714535deb4

Axsome Therapeutics (AXSM)

Financials